Last edition
News about "Biodeal Pharmaceuticals "
Biodeal Pharmaceuticals Secures INR 385 Crore Growth Investment from RMB Capitalworks
Biodeal Pharmaceuticals raises INR 385 crore from RMB Capitalworks to accelerate specialty pharma expansion, strengthen manufacturing capabilities and expand its presence across global regulated markets.
Biodeal Pharmaceuticals | 11/08/2026 | By News Bureau | 102
Biodeal Pharmaceuticals Concludes Piramal Alternatives Partnership
Biodeal delivered strong revenue growth during the hold period, with EBITDA margins improving alongside continued investment in manufacturing and governance.
Biodeal Pharmaceuticals | 28/07/2026 | By News Bureau | 112
Piramal Alternatives Announces Investment of INR 110 Crore in Biodeal
Piramal Alternatives has made a significant investment of INR 110 Crore in Biodeal Pharmaceuticals Ltd., a leading contract development and manufacturing company, facilitated through convertible instruments from its Performing Credit Fund.
Biodeal Pharmaceuticals | 08/04/2024 | By Aishwarya | 716
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy